GTF2E2 is a novel biomarker for recurrence after surgery and promotes progression of esophageal squamous cell carcinoma via miR-139-5p/GTF2E2/FUS axis
Open Access
- 2 December 2021
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 41 (6) , 782-796
Abstract
Esophageal squamous cell carcinoma (ESCC) is one of the most lethal gastrointestinal malignancies with high mortality. Recurrence develops within only a few years after curative resection and perioperative adjuvant therapy in 30–50% of these patients. Therefore, it is essential to identify postoperative recurrence biomarkers to facilitate selecting the following surveillance and therapeutic strategies. The general transcription factor IIE subunit beta (GTF2E2) is crucial for physiological and pathological functions, but its roles in the aggression and recurrence of ESCC remain ambiguous. In this study, we found that GTF2E2 was highly expressed in ESCC samples, and elevated GTF2E2 expression predicted early recurrence after surgery for ESCC patients. High expression of GTF2E2 associated with more aggressive clinic features and poor prognosis. GTF2E2 promoted the proliferation and mobility of ESCC cells in vitro and in vivo. We further revealed that miR-139-5p repressed GTF2E2 expression by downregulating its mRNA through binding with Argonaute 2 (Ago2). Rescue assays suggested that miR-139-5p affected GTF2E2-mediated ESCC progression. Moreover, GTF2E2 positively interacted with FUS promoter and regulated FUS expression, and the phenotype changes caused by GTF2E2 manipulation were recovered by rescuing FUS expression in ESCC cells. Additionally, we demonstrated that GTF2E2 promotes ESCC cells progression via activation of the AKT/ERK/mTOR pathway. In conclusion, GTF2E2 may serve as a novel biomarker for recurrence after surgery and a potential therapeutic target for ESCC patients, and it promotes ESCC progression via miR-139-5p/GTF2E2/FUS axis.Keywords
Funding Information
- National Natural Science Foundation of China (81572934;82172825)
This publication has 46 references indexed in Scilit:
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq dataNucleic Acids Research, 2013
- Tumor-Suppressive Function of miR-139-5p in Esophageal Squamous Cell CarcinomaPLOS ONE, 2013
- Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinomaOncology Reports, 2012
- Identification of Cellular Proteins Required for Replication of Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 2012
- The Structure of Human Argonaute-2 in Complex with miR-20aCell, 2012
- miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomesJournal of Biomedical Informatics, 2011
- Early Recurrence and Death After Esophagectomy in Patients With Esophageal Squamous Cell CarcinomaThe Annals of Thoracic Surgery, 2011
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- MicroRNAsCell, 2004
- Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent diseaseCancer, 2003